The effect of pharmaceuticals on the kinetics of methanogenesis and acetogenesis

M S Fountoulakis1, K Stamatelatou, G Lyberatos

  • 1Laboratory of Biochemical Engineering and Environmental Technology, Department of Chemical Engineering, University of Patras, University Campus, Rio, GR-26500 Patras, Greece. m_fountoul@chemeng.upatras.gr

Bioresource Technology
|February 19, 2008
PubMed

Insights

Propranolol hydrochloride, ofloxacin, and diclofenac sodium were studied for their impact on anaerobic digestion. Propranolol hydrochloride showed the strongest inhibition of key microorganisms involved in the process.

Area of Science:

  • Environmental microbiology
  • Biochemical engineering
  • Wastewater treatment

Background:

  • Pharmaceuticals in wastewater pose risks to microbial processes.
  • Anaerobic digestion is crucial for organic waste treatment.
  • Acetogens and acetoclastic methanogens are sensitive to contaminants.

Purpose of the Study:

  • To simulate the inhibitory effects of propranolol hydrochloride, ofloxacin, and diclofenac sodium on anaerobic digestion.
  • To quantify the impact of these pharmaceuticals on acetogens and acetoclastic methanogens.
  • To estimate inhibition constants for pharmaceutical compounds.

Main Methods:

  • Utilized the anaerobic digestion model (ADM1) for simulations.
  • Estimated kinetic parameters (maximum consumption rate, saturation constant) by fitting ADM1 to experimental data.
  • Employed a modified non-competitive inhibition function to determine inhibition constants from batch experiments at varying pharmaceutical concentrations.

Main Results:

  • Propranolol hydrochloride exhibited the most significant inhibitory effect on both acetogens and acetoclastic methanogens.
  • Kinetic parameters for acetate and propionate degraders were successfully estimated.
  • Inhibition constants were determined for the tested pharmaceuticals.

Conclusions:

  • Propranolol hydrochloride poses the highest risk to anaerobic digestion efficiency among the tested pharmaceuticals.
  • The ADM1 model, with modified inhibition functions, is effective for assessing pharmaceutical impacts.
  • Understanding pharmaceutical inhibition is vital for maintaining effective wastewater treatment processes.

Related Concept Videos

Microbes and Methanogenesis01:26

Microbes and Methanogenesis

Methanogenesis is a critical microbial process in anaerobic ecosystems responsible for the biological production of methane, a potent greenhouse gas and valuable biofuel. This metabolic pathway is primarily facilitated by methanogenic archaea, which thrive in anoxic environments such as wetlands, sediments, and animal gastrointestinal tracts. The absence of oxygen in these habitats prevents aerobic respiration, thereby favoring alternative biochemical pathways for organic matter degradation.In...
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs01:21

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in determining the metabolic...
Overview of Archaea01:29

Overview of Archaea

Archaea, named after the Archaean eon, represent a unique domain of life, distinct from bacteria and eukaryotes, with remarkable traits. Their cellular and molecular features, ecological adaptability, and industrial relevance highlight their importance in understanding life processes and leveraging biotechnology.Cellular and Molecular CharacteristicsA defining feature of archaea is their unique membrane composition. Archaeal membranes contain ether-linked isoprenoid lipids, which confer...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Metabolism of Chemolithotrophs01:15

Metabolism of Chemolithotrophs

Chemolithotrophs are microorganisms that obtain energy by oxidizing inorganic molecules such as hydrogen gas (H₂), ammonia (NH₃), reduced sulfur compounds (H₂S, S²⁻), and ferrous iron (Fe²⁺). Unlike heterotrophic organisms that rely on organic carbon, chemolithotrophs transfer electrons from these inorganic donors to the electron transport chain (ETC), generating a proton motive force (PMF) that drives ATP synthesis through oxidative phosphorylation. However, because inorganic electron donors...
Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...